Feedback
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
CORRECT!
Faculty & Disclosures
Dr Mitchell L Shiffman
Bon Secours Liver Institute, Richmond, VA, USA
Dr Mitchell L Shiffman is the director of the Liver Institute of Virginia at Bon Secours Mercy Health, Richmond, VA, USA, which he founded in 2010. read more
He graduated from the State University of New York Upstate Medical Center in Syracuse before completing residency training in internal medicine and a fellowship training in gastroenterology and hepatology at the Medical College of Virginia in Richmond. From 1990 to 2009, Dr Shiffman was chief of the Hepatology Section and medical director of the Liver Transplant Program at the Virginia Commonwealth University Medical Center in Richmond.
Dr Shiffman has published over 350 articles in peer- reviewed medical journals, invited reviews and/or book chapters; has edited three textbooks on liver disease; and has been the guest editor for two issues of Clinics in Liver Disease.
He is a fellow of the American Association for the Study of Liver Diseases (AASLD), was a member of the board of trustees of the American College of Gastroenterology (ACG) from 2004 to 2010, and has been recognized as a Master Physician of the ACG.
Dr Mitchell L Shiffman discloses: Advisory board or panel fees from CymaBay, Exelixis, Gilead, HepQuant, Intercept, Ipsen and Mirum. Grants/research support from 89 Bio, Akero, Altimmune, Camurus, Durect, Galectin, Genentech, Gilead, HepQuant, Hamni, High Tide, Intercept, Inventiva, Ipsen, Madrigal, Mirum, Novo Nordisk, Oncoustics, Pliant, Salix, Viking Therapeutics and Zydus. Speaker Bureau fees from Genentech, Gilead, Intercept, Ipsen, Madrigal and Mallinckrodt.
